Product Images Gleevec
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Gleevec NDC 0078-0649 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Imatinib structural formula - gleevec 01
Figure 1 Progression Free Survival (ITT Principle) - gleevec 02
Figure 2 Time to Progression to AP or BC (ITT Principle) - gleevec 03
Figure 3: Study 1 Recurrence-Free Survival (ITT Population) - gleevec 04
Figure 4: Study 2 Recurrence-Free Survival (ITT Population) - gleevec 05
Figure 5: Study 2 Overall Survival (ITT Population) - gleevec 06
PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 100 MG TABLETS - gleevec 07
This appears to be a mix of random letters, numbers, and symbols, with some mentioning of tablets containing imatirib mesylate. As a result, a useful description cannot be generated. It is likely that the text was not accurately recognized by the tool or sections of a document were scanned instead of an intended page.*
PRINCIPAL DISPLAY PANEL – PACKAGE LABEL – 400 MG TABLETS - gleevec 08
This is the description for the medicine Gleevec. Gleevec is a medicine containing Imatinib Mesylate used in the treatment of cancer. Each tablet contains 400 mg of the active ingredient. The product is prescription-only. It should be stored in USP-controlled room temperature and protected from moisture. The text also contains manufacturing information, dosage instructions, and safety information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.